Publikationen von Jana Rödig
Alle Typen
Zeitschriftenartikel (5)
2013
Zeitschriftenartikel
97 (1), S. 111 - 122 (2013)
CAP, a new human suspension cell line for influenza virus production. Applied Microbiology and Biotechnology
Zeitschriftenartikel
190 (1), S. 220 - 230 (2013)
Toward Animal Cell Culture-based Influenza Vaccine Design: Viral Hemagglutinin N-Glycosylation Markedly Impacts Immunogenicity. The Journal of Immunology
Zeitschriftenartikel
110 (6), S. 1691 - 1703 (2013)
Impact of Cultivation Conditions on N-glycosylation of Influenza Virus A Hemagglutinin Produced in MDCK Cell Culture. Biotechnology and Bioengineering 2011
Zeitschriftenartikel
30 (4-6), S. 281 - 290 (2011)
Impact of Influenza Virus Adaptation Status on HA N-Glycosylation Patterns in Cell Culture-Based Vaccine Production. Journal of Carbohydrate Chemistry
Zeitschriftenartikel
6 (12), e27989 (2011)
Impact of Host Cell Line Adaptation on Quasispecies Composition and Glycosylation of Influenza A Virus Hemagglutinin. PLoS One Buchkapitel (1)
2014
Buchkapitel
Vaccine production: Upstream processing with adherent or suspension cell lines. In: Animal Cell Biotechnology: Methods and Protocols, S. 371 - 393 (Hg. Pörtner, R.). HUMANA Press Inc., New York (2014)
Konferenzbeitrag (1)
2012
Konferenzbeitrag
Optimized CGE-LIF-based glycan analysis for high-throughput applications. In: ESACT - Proceedings of the 21st Annual meeting of the European Society for animal cell technology (ESACT), S. 599 - 603 (Hg. Jenkins, N.; Barron, N.; Alves, P.). 21st ESACT Meeting, Dublin, Ireland, 07. Juni 2009 - 10. Juni 2009. (2012)
Meeting Abstract (2)
2011
Meeting Abstract
28 (5 - Special Issue : XXI International Symposium on Glycoconjugates), S. 305. 21st International Symposium on Glycoconjugates (Glyco 21), Wien, Östereich, 21. August 2011 - 26. August 2011. (2011)
Impact of Influenza A virus hemagglutinin N-glycosylation on immunogenicity. In Glycoconjugate Journal,
Meeting Abstract
5 (S8 ), P113. 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies
, Vienna, Austria, 15. Mai 2011 - 18. Mai 2011. (2011)
Impact of different influenza cultivation conditions on HA N-glycosylation. In BMC Proceedings, Vortrag (7)
2012
Vortrag
Process Conditions can markedly affect the N-glycosylation pattern and immunogenicity of influenza A virus. ACTIP Meeting, Marburg (2012)
Vortrag
Impact of process conditions on influenza A virus HA N-glycosylation and immunogenicity. ProcessNet-Jahrestagung und 30. DECHEMA-Jahrestagung der Biotechnologen, Karlsruhe (2012)
2011
Vortrag
Influenza virus production: characteristics of different producer cell lines. 10th PEACe 2011, Cascais, Portugal (2011)
Vortrag
High-Throughput Glycosylation Pattern Analysis of Glycoproteins (Utilizing a Multiplexing Capillary-DNA-Sequencer). DECHEMA Frühjahrssitzung Biotechnologie, Dechemahaus, Frankfurt, Germany (2011)
2010
Vortrag
Towards High-Throughput Characterization of Carbohydrates Using a Capillary DNA-Sequencer. Colloqium at the MPI of Colloids and Interfaces, Dahlem/Berlin, Germany (2010)
Vortrag
Glycosylation Pattern Analysis of Viral Antigens. 1st Workshop European Network on Viral Vaccine Processes (ENVVP), Dechema Haus, Frankfurt, Germany (2010)
2009
Vortrag
Towards High Throughput Characterization of Glycosylation-Patterns Using a Capillary-DNA-Sequencer. CE in Biotechnology & Pharmaceutical Industries: 11th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2009), Boston, MA, USA (2009)
Poster (7)
2012
Poster
Glycosylation matters: role of viral hemagglutinin N-glycosylation in immunogenicity. European Congress of Immunology, Glasgow, Scotland (2012)
2011
Poster
Impact of influenza A virus hemagglutinin N-glycosylation on immunogenicity. 5th Glycan Forum, Berlin, Germany (2011)
Poster
Impact of different influenza cultivation conditions on HA N-glycosylation. 22nd ESACT Meeting , Vienna, Austria (2011)
Poster
Impact of influenza virus adaptation status on HA N-glycosylation patterns in cell culture-based vaccine production. 5th Glycan Forum, Berlin, Germany (2011)